ECHO was pleased to be featured on Connecticut East This Week. Our Director of Research, Dr. Susan Johnson, shared the important role of clinical trials, while a patient shared her personal journey. Thank you to Brian Scott-Smith for allowing ECHO to share […]
Read more »Clinical trials help inform our understanding of cancer and improve prevention, diagnosis, treatment, and care.They play a significant role in the development of innovative and potentially life-saving therapies. There are many new exciting clinical trials on the horizon. Trials may be […]
Read more »Are you a healthy individual who would like to participate in a clinical trial to help identify biomarkers which may identify cancer at very early stages? Healthy is defined as at least 50 years old and never diagnosed with cancer. […]
Read more »The evERA Breast Cancer Study is looking for participants to help explore a promising study treatment for those whose breast cancer has returned or worsened, even after being treated with certain medicines and surgery. If this sounds like you or […]
Read more »Gritstone bio Inc., in collaboration with Worldwide Clinical Trials, is conducting a clinical trial of GRT C901/GRT-R902 (an investigational personalized vaccine) plus immunotherapy in patients with Advanced Stage IV Colorectal Cancer. Why is this study being done? The main purpose […]
Read more »If you have been diagnosed with muscle invasive bladder cancer, we are now offering a clinical trial for the general population. Please see the information below to learn more. If you are interested in participating in this clinical trial or […]
Read more »ECHO proudly enrolled the first patients in two genomic based studies ( MYTACTIC and KRYSTAL-7) opened within the OneOncology network. This demonstrates that innovative genomic testing affords patients the opportunity to be treated in their own community with personalized, targeted therapy. Below […]
Read more »Exact Sciences has identified ECHO as the highest enroller nationally for the cancer cohort for their Ascend 2 clinical trial. This primary endpoint of this trial is hopefully identifying biomarkers for early detection of cancer. ECHO is recruiting healthy individuals with no […]
Read more »
